克拉斯
癌症研究
胰腺癌
医学
耐火材料(行星科学)
免疫组织化学
病理
后天抵抗
癌症
细胞培养
结合
化疗
胰腺疾病
肿瘤科
癌细胞
抗药性
细胞生长
突变
放射治疗
内科学
作者
Hiroki Ozawa,Keiko Takahashi,Tomoki Motegi,Justine J. Jacobi,Atrayee Bhattacharya,Keisuke Shigeta,Shinkichi Takamori,Mai Onishi,Zhou Luan,Kazumasa Fukuda,Akihisa Ueno,Minoru Kitago,Hirofumi Kawakubo,Yuko Kitagawa,Dove Keith,John Muschler,Rosalie C. Sears,Mark D. Long,Joseph D. Mancias,Andrew J. Aguirre
标识
DOI:10.1158/1078-0432.ccr-25-2333
摘要
These findings demonstrate that M1C confers resistance of PDAC to KRAS G12D inhibition and identify M1C as a potential target for ADC treatment of patients with PDAC who are refractory to KRAS inhibitors.
科研通智能强力驱动
Strongly Powered by AbleSci AI